undamentalytics Newsletter

Whalen Kathleen M: insider trades

Officer at HCA Healthcare. No open-market purchases and 15 sales not made under a pre-set plan, reported from February 8, 2019 to November 18, 2024.

What happened after Whalen Kathleen M’s sales?

After their sales, the shares moved +3.6% against the index over 12 months on average (a negative figure means selling was the right call); 53% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

Trade by trade

Whalen Kathleen M: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 0 — — — — — — Not enough years
Purchases, 6 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the report 0 — — — — — — Not enough years
Purchases, 12 months after the trade 0 — — — — — — Not enough years
Sales, 3 months after the report 15 −2.0% −2.0% 60% 6 −1.99 0.10 No reliable evidence
Sales, 12 months after the report 15 +3.6% −0.7% 53% 6 1.27 0.26 No reliable evidence
Sales, 12 months after the trade 15 +4.9% +3.6% 47% 6 1.29 0.25 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
HCA Healthcare HCA SVP & Chief Ethics Officer015February 8, 2019November 18, 2024

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
November 18, 2024November 14, 2024 HCA Sale $527,677 −5.9%+34.7%+26.9%
July 31, 2024July 29, 2024 HCA Sale $1,756,695 −7.6%−16.1%−18.0%
May 20, 2024May 16, 2024 HCA Sale $1,045,465 +11.7%+7.8%+7.0%
February 13, 2024February 9, 2024 HCA Sale $1,305,067 +0.7%−19.7%−19.2%
August 7, 2023August 3, 2023 HCA Sale $787,320 −10.9%+16.0%+13.6%
February 22, 2023February 17, 2023 HCA Sale $457,100 +2.4%−2.8%−4.3%
May 5, 2022May 3, 2022 HCA Sale $107,690 −7.6%+20.2%+30.8%
November 4, 2021November 4, 2021 HCA Sale $955,581 −2.0%+4.8%+4.7%
July 26, 2021July 22, 2021 HCA Sale $218,753 −6.3%−9.3%−9.4%
February 5, 2021February 4, 2021 HCA Sale $49,591 +11.3%+15.0%+18.3%
November 2, 2020October 29, 2020 HCA Sale $157,752 +16.5%+45.0%+60.3%
February 11, 2020February 7, 2020 HCA Sale $286,476 −17.1%−0.7%+3.6%
November 6, 2019November 4, 2019 HCA Sale $343,433 −1.1%−13.4%−10.9%
August 15, 2019August 13, 2019 HCA Sale $124,626 +1.2%−9.9%−13.3%
February 8, 2019February 6, 2019 HCA Sale $27,896 −15.9%−17.0%−16.9%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Whalen Kathleen M traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.